BlackRock Science & Technology TrustBST

The BlackRock Science & Technology Trust (LSE: BRST) isn’t your average equity trust-it’s a closed-ended fund that promises exposure to the global science and technology sector, but its real product is a regulatory wrapper, a sales pitch, and a pile of unit trusts you can’t actually buy directly. The fund itself is a listed investment company, not a tech incubator, and its ‘science and technology’ label is shorthand for a diversified portfolio of global tech giants, semiconductor makers, and software companies, all stitched together under the BlackRock brand. The trust’s job is to deliver long-term capital growth by owning the stocks that underpin the digital economy, not to invent the next AI unicorn.

What the fund actually does is simple: it buys shares in technology and science-driven businesses, holds them, and distributes dividends to shareholders while charging an annual management fee for the privilege. The ‘science and technology’ label is broad enough to include biotech, semiconductors, software, and even some industrial tech, but it excludes the kind of speculative, pre-revenue startups that make headlines. In practice, the trust is a diversified tech ETF in a different wrapper-less liquid, more expensive, and with a closed-ended structure that means its price can drift from its net asset value. The fund’s real customers are retail and institutional investors who want tech exposure without the hassle of stock-picking or the volatility of a single stock.

The fund’s latest published factsheets and product pages confirm it is a closed-ended investment company authorised under UK regulations, with its shares listed on the London Stock Exchange. The trust does not file standalone revenue or profit numbers because it is not a trading business-it’s a holding company for other companies’ shares. Instead, its performance is measured by net asset value per share, dividend yield, and discount/premium to NAV. The trust’s management team is run by BlackRock Investment Management (UK) Limited, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority. The fund’s product pages and factsheets are the primary source of operational data, and they confirm the trust’s investment mandate, fee structure, and regulatory status. There is no evidence of recent earnings releases, revenue growth, or cash-flow statements because the trust does not operate as a trading company; its financials are embedded in the performance of its underlying portfolio.

The fund’s share price is quoted on the London Stock Exchange, and its performance is tracked by investment platforms and data providers, but the trust does not provide a dedicated chart route in the evidence supplied. The fund’s discount to net asset value is a key metric for investors, as it indicates how much the market is willing to pay above or below the value of the underlying assets. The trust’s product pages and factsheets are the primary sources for NAV, dividend history, and fee disclosures, and they confirm the trust’s closed-ended structure and regulatory authorisation. The fund’s investment mandate is to invest in global science and technology companies, with a focus on long-term capital growth.

The evidence supplied does not include any recent developments, filings, or earnings data specific to the BlackRock Science & Technology Trust itself. The product pages and factsheets confirm the trust’s regulatory status, investment mandate, and fee structure, but they do not provide standalone financial statements, revenue, or profit figures. The trust’s performance is driven by the performance of its underlying portfolio, which is not itemised in the evidence provided. The fund’s product pages and factsheets are the primary sources for operational details, and they confirm the trust’s closed-ended structure and regulatory authorisation. The fund’s investment mandate is broad, covering global science and technology companies, but the evidence does not provide a breakdown of holdings, sector allocations, or geographic exposure.

The fund’s product pages and factsheets confirm that BlackRock Investment Management (UK) Limited has not examined the websites linked to its products and does not assume responsibility for their contents. This is a reminder that the fund’s marketing materials are curated, but the underlying investments are subject to the risks of the global tech sector, including regulatory changes, competition, and technological disruption. The fund’s product pages and factsheets are the primary sources for operational details, and they confirm the trust’s regulatory status and investment mandate.